In addition to weight loss, GLP-1 therapy may reduce circulating insulin and testosterone levels, which can further support hormonal balance and ovulatory function
How Major Chains Are Already Responding The national chains that have moved first on GLP-1 adaptation share a common strategic logic: protein-forward positioning, portion optionality, and explicit callouts of nutrient density


FIGURE 1 Activating the Transient Receptor Potential Vanilloid 1 and Cannabinoid 1 Receptors Acetaminophen is first metabolized to p -aminophenol, which easily crosses the blood-brain barrier and is converted to AM404 by fatty acid amide hydrolase ( N -acetyl- p -benzoquinoneimine (NAPQI), which also appears to produce analgesia by activating transient receptor potential ankyrin 1 receptors ( Similar to the brain, it is also known that the spinal cord, especially SG neurons, is critical to pain pathways, and modulates nociceptive transmission via primary afferent A- and C-fibers ( c-fos -positive immunoreactivity induced by non-noxious stimulation of the spinal cord in a rat model of neuropathic or inflammatory pain, and these responses are inhibited by TRPV1 or CB1 receptor antagonists ( in vivo and in vitro whole-cell patch-clamp recordings with nave rats ( in vivo and in vitro whole-cell patch-clamp recordings of SG neurons in the spinal cord dorsal horn and recorded the excitatory post-synaptic currents (EPSCs)

Microscopic liposomes are rapidly absorbed through the oral mucosa and lymphatic system, enabling direct intracellular delivery at levels that can surpass traditional intravenous therapies
Two recent studies in the JCI provide insight into the neurons responsible for this effect